Find A Physician
Return to Cardiovascular Research Foundation Overview
More on Cardiovascular Research Foundation
Hospital News
Return to Cardiovascular Research Foundation Overview
More on Cardiovascular Research Foundation
Research and Clinical Trials
Return to Cardiovascular Research Foundation Overview
More on Cardiovascular Research Foundation
Health Library
Return to Cardiovascular Research Foundation Overview
More on Cardiovascular Research Foundation
Clinical Services
Return to Cardiovascular Research Foundation Overview
More on Cardiovascular Research Foundation
Cardiovascular Research Foundation
Back to the nypheart.org Home Page
The Cardiovascular Research Foundation is an organization that was founded to combine the elements of research, education and patient care in the treatment of cardiovascular disease. The primary affiliation of CRF is with the Center for Interventional Vascular Therapy (CIVT) at Columbia University Medical Center, which provides necessary state-of-the-art technology to support CRF's cutting-edge research and whose faculty members serve as research-physicians that drive CRF's ground-breaking achievements.
With its rich network of collaborators in academia and industry, the CRF has pioneered new and innovative less invasive procedures and new drug-based therapies, and has advanced the world's physicians treat atherosclerotic heart and vascular diseases. The CRF develops new cardiovascular technologies, as well as working as a collaborator with institutions developing tools and techniques in preclinical facilities, moving them into the clinic using the physicians and resources of NewYork-Presbyterian Hsopital to do first-in-human studies.
Through its collaboration with CRF, Columbia University Medical Center co-hosts the annual Transcatheter Cardiovascular Therapeutics symposium—the world's largest meeting in interventional cardiology and vascular medicine. At the TCT, over 10,000 registrants from 80 countries learn the latest interventional techniques.
Last Modified: 08/17/2009



